<Record>
<Term>Anidulafungin</Term>
<SemanticType>Pharmacologic Substance</SemanticType>
<SemanticType>Organic Chemical</SemanticType>
<ParentTerm>Antifungal Agent</ParentTerm>
<ClassificationPath>Chemicals_and_Drugs_Kind/Drug, Food, Chemical or Biomedical Material/Pharmacologic Substance/Anti-Infective Agent/Antifungal Agent/Anidulafungin</ClassificationPath>
<BroaderTerm>Chemicals_and_Drugs_Kind</BroaderTerm>
<BroaderTerm>Antifungal Agent</BroaderTerm>
<BroaderTerm>Pharmacologic Substance</BroaderTerm>
<BroaderTerm>Anidulafungin</BroaderTerm>
<BroaderTerm>Anti-Infective Agent</BroaderTerm>
<BroaderTerm>Drug, Food, Chemical or Biomedical Material</BroaderTerm>
<Synonym>LY303366</Synonym>
<Synonym>Eraxis</Synonym>
<Synonym>Anidulafungin</Synonym>
<Synonym>ANIDULAFUNGIN</Synonym>
<Description>A cyclic lipopeptide echinocandin derivative with antifungal activity.  Anidulafungin inhibits 1,3 beta-D-glucan synthase, an enzyme involved in fungal cell wall synthesis, resulting in cell lysis and death. This agent is active against Candida species and Aspergillus. (NCI04)</Description>
<Source>FDA Registry</Source>
<Source>NCI Thesaurus</Source>
</Record>
